Global Cancers Immunotherapy Drugs Market Size, Status and Forecast 2020-2026

August 2020 | 91 pages | ID: GCB03E45BA77EN
QYResearch

Abstracts

Cancers Immunotherapy Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cancers Immunotherapy Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study

• Roche
• Pfizer
• Merck
• Novartis
• Johnson & Johnson
• Sanofi
• GlaxoSmithKline
• Amgen
• AbbVie
• Boehringer Ingelheim
• AstraZeneca
• Immatics Biotechnologies

Market segment by Type, the product can be split into

• Monoclonal Antibodies
• Check Point Inhibitors
• Interferons
• Interleukins

Market segment by Application, split into

• Lung Cancer
• Liver Cancer
• Colorectal Cancer
• Pancreatic Cancer
• Breast Cancer
• Other Cancers

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cancers Immunotherapy Drugs Revenue
1.4 Market by Type
  1.4.1 Global Cancers Immunotherapy Drugs Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Monoclonal Antibodies
  1.4.3 Check Point Inhibitors
  1.4.4 Interferons
  1.4.5 Interleukins
1.5 Market by Application
  1.5.1 Global Cancers Immunotherapy Drugs Market Share by Application: 2020 VS 2026
  1.5.2 Lung Cancer
  1.5.3 Liver Cancer
  1.5.4 Colorectal Cancer
  1.5.5 Pancreatic Cancer
  1.5.6 Breast Cancer
  1.5.7 Other Cancers
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Global Cancers Immunotherapy Drugs Market Perspective (2015-2026)
2.2 Global Cancers Immunotherapy Drugs Growth Trends by Regions
  2.2.1 Cancers Immunotherapy Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Cancers Immunotherapy Drugs Historic Market Share by Regions (2015-2020)
  2.2.3 Cancers Immunotherapy Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Cancers Immunotherapy Drugs Market Growth Strategy
  2.3.6 Primary Interviews with Key Cancers Immunotherapy Drugs Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Cancers Immunotherapy Drugs Players by Market Size
  3.1.1 Global Top Cancers Immunotherapy Drugs Players by Revenue (2015-2020)
  3.1.2 Global Cancers Immunotherapy Drugs Revenue Market Share by Players (2015-2020)
  3.1.3 Global Cancers Immunotherapy Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cancers Immunotherapy Drugs Market Concentration Ratio
  3.2.1 Global Cancers Immunotherapy Drugs Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Cancers Immunotherapy Drugs Revenue in 2019
3.3 Cancers Immunotherapy Drugs Key Players Head office and Area Served
3.4 Key Players Cancers Immunotherapy Drugs Product Solution and Service
3.5 Date of Enter into Cancers Immunotherapy Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 MARKET SIZE BY TYPE (2015-2026)

4.1 Global Cancers Immunotherapy Drugs Historic Market Size by Type (2015-2020)
4.2 Global Cancers Immunotherapy Drugs Forecasted Market Size by Type (2021-2026)

5 MARKET SIZE BY APPLICATION (2015-2026)

5.1 Global Cancers Immunotherapy Drugs Market Size by Application (2015-2020)
5.2 Global Cancers Immunotherapy Drugs Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Cancers Immunotherapy Drugs Market Size (2015-2020)
6.2 Cancers Immunotherapy Drugs Key Players in North America (2019-2020)
6.3 North America Cancers Immunotherapy Drugs Market Size by Type (2015-2020)
6.4 North America Cancers Immunotherapy Drugs Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Cancers Immunotherapy Drugs Market Size (2015-2020)
7.2 Cancers Immunotherapy Drugs Key Players in Europe (2019-2020)
7.3 Europe Cancers Immunotherapy Drugs Market Size by Type (2015-2020)
7.4 Europe Cancers Immunotherapy Drugs Market Size by Application (2015-2020)

8 CHINA

8.1 China Cancers Immunotherapy Drugs Market Size (2015-2020)
8.2 Cancers Immunotherapy Drugs Key Players in China (2019-2020)
8.3 China Cancers Immunotherapy Drugs Market Size by Type (2015-2020)
8.4 China Cancers Immunotherapy Drugs Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Cancers Immunotherapy Drugs Market Size (2015-2020)
9.2 Cancers Immunotherapy Drugs Key Players in Japan (2019-2020)
9.3 Japan Cancers Immunotherapy Drugs Market Size by Type (2015-2020)
9.4 Japan Cancers Immunotherapy Drugs Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Cancers Immunotherapy Drugs Market Size (2015-2020)
10.2 Cancers Immunotherapy Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cancers Immunotherapy Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Cancers Immunotherapy Drugs Market Size by Application (2015-2020)

11 INDIA

11.1 India Cancers Immunotherapy Drugs Market Size (2015-2020)
11.2 Cancers Immunotherapy Drugs Key Players in India (2019-2020)
11.3 India Cancers Immunotherapy Drugs Market Size by Type (2015-2020)
11.4 India Cancers Immunotherapy Drugs Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Cancers Immunotherapy Drugs Market Size (2015-2020)
12.2 Cancers Immunotherapy Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Cancers Immunotherapy Drugs Market Size by Type (2015-2020)
12.4 Central & South America Cancers Immunotherapy Drugs Market Size by Application (2015-2020)

13KEY PLAYERS PROFILES

13.1 Roche
  13.1.1 Roche Company Details
  13.1.2 Roche Business Overview
  13.1.3 Roche Cancers Immunotherapy Drugs Introduction
  13.1.4 Roche Revenue in Cancers Immunotherapy Drugs Business (2015-2020))
  13.1.5 Roche Recent Development
13.2 Pfizer
  13.2.1 Pfizer Company Details
  13.2.2 Pfizer Business Overview
  13.2.3 Pfizer Cancers Immunotherapy Drugs Introduction
  13.2.4 Pfizer Revenue in Cancers Immunotherapy Drugs Business (2015-2020)
  13.2.5 Pfizer Recent Development
13.3 Merck
  13.3.1 Merck Company Details
  13.3.2 Merck Business Overview
  13.3.3 Merck Cancers Immunotherapy Drugs Introduction
  13.3.4 Merck Revenue in Cancers Immunotherapy Drugs Business (2015-2020)
  13.3.5 Merck Recent Development
13.4 Novartis
  13.4.1 Novartis Company Details
  13.4.2 Novartis Business Overview
  13.4.3 Novartis Cancers Immunotherapy Drugs Introduction
  13.4.4 Novartis Revenue in Cancers Immunotherapy Drugs Business (2015-2020)
  13.4.5 Novartis Recent Development
13.5 Johnson & Johnson
  13.5.1 Johnson & Johnson Company Details
  13.5.2 Johnson & Johnson Business Overview
  13.5.3 Johnson & Johnson Cancers Immunotherapy Drugs Introduction
  13.5.4 Johnson & Johnson Revenue in Cancers Immunotherapy Drugs Business (2015-2020)
  13.5.5 Johnson & Johnson Recent Development
13.6 Sanofi
  13.6.1 Sanofi Company Details
  13.6.2 Sanofi Business Overview
  13.6.3 Sanofi Cancers Immunotherapy Drugs Introduction
  13.6.4 Sanofi Revenue in Cancers Immunotherapy Drugs Business (2015-2020)
  13.6.5 Sanofi Recent Development
13.7 GlaxoSmithKline
  13.7.1 GlaxoSmithKline Company Details
  13.7.2 GlaxoSmithKline Business Overview
  13.7.3 GlaxoSmithKline Cancers Immunotherapy Drugs Introduction
  13.7.4 GlaxoSmithKline Revenue in Cancers Immunotherapy Drugs Business (2015-2020)
  13.7.5 GlaxoSmithKline Recent Development
13.8 Amgen
  13.8.1 Amgen Company Details
  13.8.2 Amgen Business Overview
  13.8.3 Amgen Cancers Immunotherapy Drugs Introduction
  13.8.4 Amgen Revenue in Cancers Immunotherapy Drugs Business (2015-2020)
  13.8.5 Amgen Recent Development
13.9 AbbVie
  13.9.1 AbbVie Company Details
  13.9.2 AbbVie Business Overview
  13.9.3 AbbVie Cancers Immunotherapy Drugs Introduction
  13.9.4 AbbVie Revenue in Cancers Immunotherapy Drugs Business (2015-2020)
  13.9.5 AbbVie Recent Development
13.10 Boehringer Ingelheim
  13.10.1 Boehringer Ingelheim Company Details
  13.10.2 Boehringer Ingelheim Business Overview
  13.10.3 Boehringer Ingelheim Cancers Immunotherapy Drugs Introduction
  13.10.4 Boehringer Ingelheim Revenue in Cancers Immunotherapy Drugs Business (2015-2020)
  13.10.5 Boehringer Ingelheim Recent Development
13.11 AstraZeneca
  10.11.1 AstraZeneca Company Details
  10.11.2 AstraZeneca Business Overview
  10.11.3 AstraZeneca Cancers Immunotherapy Drugs Introduction
  10.11.4 AstraZeneca Revenue in Cancers Immunotherapy Drugs Business (2015-2020)
  10.11.5 AstraZeneca Recent Development
13.12 Immatics Biotechnologies
  10.12.1 Immatics Biotechnologies Company Details
  10.12.2 Immatics Biotechnologies Business Overview
  10.12.3 Immatics Biotechnologies Cancers Immunotherapy Drugs Introduction
  10.12.4 Immatics Biotechnologies Revenue in Cancers Immunotherapy Drugs Business (2015-2020)
  10.12.5 Immatics Biotechnologies Recent Development

14ANALYST'S VIEWPOINTS/CONCLUSIONS

15APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Cancers Immunotherapy Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Cancers Immunotherapy Drugs Revenue
Table 3. Ranking of Global Top Cancers Immunotherapy Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cancers Immunotherapy Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Monoclonal Antibodies
Table 6. Key Players of Check Point Inhibitors
Table 7. Key Players of Interferons
Table 8. Key Players of Interleukins
Table 9. Global Cancers Immunotherapy Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Cancers Immunotherapy Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Cancers Immunotherapy Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Cancers Immunotherapy Drugs Market Share by Regions (2015-2020)
Table 13. Global Cancers Immunotherapy Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Cancers Immunotherapy Drugs Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Cancers Immunotherapy Drugs Market Growth Strategy
Table 19. Main Points Interviewed from Key Cancers Immunotherapy Drugs Players
Table 20. Global Cancers Immunotherapy Drugs Revenue by Players (2015-2020) (Million US$)
Table 21. Global Cancers Immunotherapy Drugs Market Share by Players (2015-2020)
Table 22. Global Top Cancers Immunotherapy Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancers Immunotherapy Drugs as of 2019)
Table 23. Global Cancers Immunotherapy Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Cancers Immunotherapy Drugs Product Solution and Service
Table 26. Date of Enter into Cancers Immunotherapy Drugs Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Cancers Immunotherapy Drugs Market Size by Type (2015-2020) (Million US$)
Table 29. Global Cancers Immunotherapy Drugs Market Size Share by Type (2015-2020)
Table 30. Global Cancers Immunotherapy Drugs Revenue Market Share by Type (2021-2026)
Table 31. Global Cancers Immunotherapy Drugs Market Size Share by Application (2015-2020)
Table 32. Global Cancers Immunotherapy Drugs Market Size by Application (2015-2020) (Million US$)
Table 33. Global Cancers Immunotherapy Drugs Market Size Share by Application (2021-2026)
Table 34. North America Key Players Cancers Immunotherapy Drugs Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Cancers Immunotherapy Drugs Market Share (2019-2020)
Table 36. North America Cancers Immunotherapy Drugs Market Size by Type (2015-2020) (Million US$)
Table 37. North America Cancers Immunotherapy Drugs Market Share by Type (2015-2020)
Table 38. North America Cancers Immunotherapy Drugs Market Size by Application (2015-2020) (Million US$)
Table 39. North America Cancers Immunotherapy Drugs Market Share by Application (2015-2020)
Table 40. Europe Key Players Cancers Immunotherapy Drugs Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Cancers Immunotherapy Drugs Market Share (2019-2020)
Table 42. Europe Cancers Immunotherapy Drugs Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Cancers Immunotherapy Drugs Market Share by Type (2015-2020)
Table 44. Europe Cancers Immunotherapy Drugs Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Cancers Immunotherapy Drugs Market Share by Application (2015-2020)
Table 46. China Key Players Cancers Immunotherapy Drugs Revenue (2019-2020) (Million US$)
Table 47. China Key Players Cancers Immunotherapy Drugs Market Share (2019-2020)
Table 48. China Cancers Immunotherapy Drugs Market Size by Type (2015-2020) (Million US$)
Table 49. China Cancers Immunotherapy Drugs Market Share by Type (2015-2020)
Table 50. China Cancers Immunotherapy Drugs Market Size by Application (2015-2020) (Million US$)
Table 51. China Cancers Immunotherapy Drugs Market Share by Application (2015-2020)
Table 52. Japan Key Players Cancers Immunotherapy Drugs Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Cancers Immunotherapy Drugs Market Share (2019-2020)
Table 54. Japan Cancers Immunotherapy Drugs Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Cancers Immunotherapy Drugs Market Share by Type (2015-2020)
Table 56. Japan Cancers Immunotherapy Drugs Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Cancers Immunotherapy Drugs Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Cancers Immunotherapy Drugs Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Cancers Immunotherapy Drugs Market Share (2019-2020)
Table 60. Southeast Asia Cancers Immunotherapy Drugs Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Cancers Immunotherapy Drugs Market Share by Type (2015-2020)
Table 62. Southeast Asia Cancers Immunotherapy Drugs Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Cancers Immunotherapy Drugs Market Share by Application (2015-2020)
Table 64. India Key Players Cancers Immunotherapy Drugs Revenue (2019-2020) (Million US$)
Table 65. India Key Players Cancers Immunotherapy Drugs Market Share (2019-2020)
Table 66. India Cancers Immunotherapy Drugs Market Size by Type (2015-2020) (Million US$)
Table 67. India Cancers Immunotherapy Drugs Market Share by Type (2015-2020)
Table 68. India Cancers Immunotherapy Drugs Market Size by Application (2015-2020) (Million US$)
Table 69. India Cancers Immunotherapy Drugs Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Cancers Immunotherapy Drugs Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Cancers Immunotherapy Drugs Market Share (2019-2020)
Table 72. Central & South America Cancers Immunotherapy Drugs Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Cancers Immunotherapy Drugs Market Share by Type (2015-2020)
Table 74. Central & South America Cancers Immunotherapy Drugs Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Cancers Immunotherapy Drugs Market Share by Application (2015-2020)
Table 76. Roche Company Details
Table 77. Roche Business Overview
Table 78. Roche Product
Table 79. Roche Revenue in Cancers Immunotherapy Drugs Business (2015-2020) (Million US$)
Table 80. Roche Recent Development
Table 81. Pfizer Company Details
Table 82. Pfizer Business Overview
Table 83. Pfizer Product
Table 84. Pfizer Revenue in Cancers Immunotherapy Drugs Business (2015-2020) (Million US$)
Table 85. Pfizer Recent Development
Table 86. Merck Company Details
Table 87. Merck Business Overview
Table 88. Merck Product
Table 89. Merck Revenue in Cancers Immunotherapy Drugs Business (2015-2020) (Million US$)
Table 90. Merck Recent Development
Table 91. Novartis Company Details
Table 92. Novartis Business Overview
Table 93. Novartis Product
Table 94. Novartis Revenue in Cancers Immunotherapy Drugs Business (2015-2020) (Million US$)
Table 95. Novartis Recent Development
Table 96. Johnson & Johnson Company Details
Table 97. Johnson & Johnson Business Overview
Table 98. Johnson & Johnson Product
Table 99. Johnson & Johnson Revenue in Cancers Immunotherapy Drugs Business (2015-2020) (Million US$)
Table 100. Johnson & Johnson Recent Development
Table 101. Sanofi Company Details
Table 102. Sanofi Business Overview
Table 103. Sanofi Product
Table 104. Sanofi Revenue in Cancers Immunotherapy Drugs Business (2015-2020) (Million US$)
Table 105. Sanofi Recent Development
Table 106. GlaxoSmithKline Company Details
Table 107. GlaxoSmithKline Business Overview
Table 108. GlaxoSmithKline Product
Table 109. GlaxoSmithKline Revenue in Cancers Immunotherapy Drugs Business (2015-2020) (Million US$)
Table 110. GlaxoSmithKline Recent Development
Table 111. Amgen Business Overview
Table 112. Amgen Product
Table 113. Amgen Company Details
Table 114. Amgen Revenue in Cancers Immunotherapy Drugs Business (2015-2020) (Million US$)
Table 115. Amgen Recent Development
Table 116. AbbVie Company Details
Table 117. AbbVie Business Overview
Table 118. AbbVie Product
Table 119. AbbVie Revenue in Cancers Immunotherapy Drugs Business (2015-2020) (Million US$)
Table 120. AbbVie Recent Development
Table 121. Boehringer Ingelheim Company Details
Table 122. Boehringer Ingelheim Business Overview
Table 123. Boehringer Ingelheim Product
Table 124. Boehringer Ingelheim Revenue in Cancers Immunotherapy Drugs Business (2015-2020) (Million US$)
Table 125. Boehringer Ingelheim Recent Development
Table 126. AstraZeneca Company Details
Table 127. AstraZeneca Business Overview
Table 128. AstraZeneca Product
Table 129. AstraZeneca Revenue in Cancers Immunotherapy Drugs Business (2015-2020) (Million US$)
Table 130. AstraZeneca Recent Development
Table 131. Immatics Biotechnologies Company Details
Table 132. Immatics Biotechnologies Business Overview
Table 133. Immatics Biotechnologies Product
Table 134. Immatics Biotechnologies Revenue in Cancers Immunotherapy Drugs Business (2015-2020) (Million US$)
Table 135. Immatics Biotechnologies Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Cancers Immunotherapy Drugs Market Share by Type: 2020 VS 2026
Figure 2. Monoclonal Antibodies Features
Figure 3. Check Point Inhibitors Features
Figure 4. Interferons Features
Figure 5. Interleukins Features
Figure 6. Global Cancers Immunotherapy Drugs Market Share by Application: 2020 VS 2026
Figure 7. Lung Cancer Case Studies
Figure 8. Liver Cancer Case Studies
Figure 9. Colorectal Cancer Case Studies
Figure 10. Pancreatic Cancer Case Studies
Figure 11. Breast Cancer Case Studies
Figure 12. Other Cancers Case Studies
Figure 13. Cancers Immunotherapy Drugs Report Years Considered
Figure 14. Global Cancers Immunotherapy Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Cancers Immunotherapy Drugs Market Share by Regions: 2020 VS 2026
Figure 16. Global Cancers Immunotherapy Drugs Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Cancers Immunotherapy Drugs Market Share by Players in 2019
Figure 19. Global Top Cancers Immunotherapy Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancers Immunotherapy Drugs as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Cancers Immunotherapy Drugs Revenue in 2019
Figure 21. North America Cancers Immunotherapy Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Cancers Immunotherapy Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Cancers Immunotherapy Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Cancers Immunotherapy Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Cancers Immunotherapy Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Cancers Immunotherapy Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Cancers Immunotherapy Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Bottom-up and Top-down Approaches for This Report
Figure 29. Data Triangulation
Figure 30. Key Executives Interviewed